Vitamin D3 Supplements on semen parameters

Phase 2

• Conditions: Health Condition 1: R69- Illness, unspecified

• Registration Number: CTRI/2020/11/028788
• Lead Sponsor: not applicable

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1 Men with low motility, morphology and sperm count ie) oligoasthenoteratozoospermia who are attending the OPD in the first setting for the treatment .(Low sperm count <15 million - oligospermia , Poor sperm movement motility <32% - asthenozoospermia ,Abnormal sperm shape morphology <4% - teratozoospermia)

2 Men with TSH and HBA1c normal levels (normal TSH 0.25-5uIU/ml, HBA1c- 4-6 % )

3 Men with Normo Gonadotropic LH and FSH normal levels (normal LH level 1.1- 7.0 mIu/ml, FSH level 1.7-12.0 mIu/ml)

Exclusion Criteria

1 Men with azospermia aspermia

2 Men with grade III or more varicocele

3 Men with history of testicular malignancy

4 Men who are using drugs including anti hypertensives, anti psychotics, anti depressants, anti epileptics and anti coagulants.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
improvement seen in the level of sperm count and motilityTimepoint: 45 days

Secondary Outcome Measures

Name	Time	Method
improvement seen in the level of sperm count and motilityTimepoint: 45 days